NMNayani P. Madarasingha

Nayani P. Madarasingha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nayani P. Madarasingha has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Topics from Tropics: Proceedings of the Second International Conference on Tropical Dermatology (ICTD 2026), Colombo, Sri Lanka, 11–14 March 2026

    by Nayani Madarasingha, Nuwangika Marcellin

    The Second International Conference on Tropical Dermatology (ICTD 2026) was held in Colombo, Sri Lanka, from 11–14 March 2026 as a joint academic initiative of the Sri Lanka College of Dermatology and Aesthetic Medicine and the German Dermatological Society. Conducted under the theme “Topics from Tropics”, the conference brought together dermatologists, researchers, and trainees from around the world to discuss contemporary developments in tropical dermatology. The programme included pre-congress workshops, plenary lectures, symposia, free paper presentations, and e-poster sessions addressing infections and infestations, pigmentary disorders, environmental dermatoses, and advances in diagnostics and therapeutics. A total of 420 delegates participated, including 297 international attendees, with contributions from 44 international experts and several regional speakers. The conference provided a platform for scientific exchange, collaborative networking, and the promotion of research related to tropical dermatoses. The successful event significantly strengthened international collaborations, secured a global trademark for Sri Lanka in connection with the conference, and laid a strong foundation for the upcoming 3rd ICTD planned for 2030. Cultural events like the “Sri Lankan Night” further enhanced the experience, leaving a lasting impression of local hospitality on the global dermatology community. This report summarizes the key highlights and academic activities of ICTD 2026.

  • Open Access

    Impact of dermatophytosis on the quality of life in a subset of patients in Colombo, Sri Lanka

    by Piyumi Kumarasinghe, Sanidi Edirisinghe, Thilinie Alahakoon, Nayani Madarasingha

    Background: Dermatophytosis is a common superficial fungal infection, which often causes pruritic and exten-sive skin lesions that can be relapsing. In tropical countries like Sri Lanka, warm and humid conditions favour their spread. Lesions often involve visible areas, and this leads to discomfort and psychosocial distress. However, the impact of clinical and socio-demographic factors on quality of life remains insufficiently studied. This study assesses the effect of dermatophytosis on quality of life in a sample of patients from the Colombo district.Methods: A cross-sectional study was conducted among 202 patients with clinically diagnosed tinea infections of glabrous skin. Data were collected using the validated Sinhala Dermatology Life Quality Index (DLQI) questionnaire. Associations of independent variables were analyzed using the Mann–Whitney U test and Spearman’s correlation tests, with significance set as P<0.05.Results: The DLQI scores ranged from 0 to 30 (mean 10.37 ± 6.68; median 9.00; IQR 11). The largest proportion of participants had a very large effect on quality of life (33.8%). Among DLQI domains, the highest impact was seen in the “symptoms and feelings”, whereas the least impact was observed in the “treatment” domain. Among the subset of 61 participants who completed the socio-demographic questionnaire, monthly income showed a significant negative correlation with DLQI (U = 314.5, P = 0.049), while education level and gender were not significantly associated. Among clinical factors, only groin involvement was significantly associated with higher DLQI scores (U = 192.5, P = 0.047). However, there’s no significant association of disease duration and time for first consultation on the DLQI score.Conclusion: Tinea infections have a considerable effect on quality of life, particularly among patients with groin involvement. Socioeconomic status, specifically income, appears as a significant determinant of disease burden. These findings highlight the importance of targeted management strategies addressing both clinical severity and psychological and socioeconomic factors.

  • Open Access

    Knowledge of dermatophytosis among medical officers at the primary care level in Sri Lanka

    by Nayani Madarasingha, Piyumi Kumarasinghe, Sanidi Edirisinghe

    Background: Chronic and recurrent Dermatophytosis has become a significant health problem in Sri Lanka. Widespread usage of steroids, inadequate doses, and durations of antifungals are contributing significantly to this problem. This scenario questions the adequacy of knowledge in primary care physicians in the management of dermatophytosis.Objectives: The study was planned to identify the level of understanding and knowledge on dermatophytosis and its management among medical officers at the primary care level.Methods: A total of 482 medical officers completed the questionnaire, which consisted of five domains containing five statements each (a total of 25 items). Results: The median knowledge score was 14 (IQR 5), and the mean score was 13.28 ± 4.34 out of a maximum of 25. A score of more than 20/ 25 was achieved by 3.1 %, and scores below 10/25 were observed in 15.5%. The percentage of correct responses for questions assessing clinical features, management, and oral antifungal therapy was below 50%. Conclusion: This study shows inadequate knowledge of dermatophytosis at the primary care level. Education of medical officers on proper management of dermatophytosis should be taken as a priority to overcome recalcitrant dermatophytosis in Sri Lanka.

  • Dermatophytosis Caused by Trichophyton indotineae (Trichophyton mentagrophytes ITS Genotype VIII) in Sri Lanka

    by Nayani P. Madarasingha, Harshini Thabrew, Silk Uhrlass, Surammika Eriyagama, Dieter Reinal, Primali I. Jayasekera, Pietro Nenoff

    : Over the past few years, a recalcitrant dermatophytosis has been observed on the Indian subcontinent, including Sri Lanka, which has caused a major public health issue in the region. An emerging species, Trichophyton indotineae, first described as Trichophyton mentagrophytes ITS genotype VIII, is thought to be responsible for this fast-spreading, mostly terbinafine-resistant dermatophytosis. Recalcitrant dermatophytosis is a challenge to dermatologists, and knowing the causative species and antifungal sensitivity in the earlier stage of management would be invaluable. We report a case series of patients with dermatophytosis caused by T. indotineae in Sri Lanka. This is the first detection of this highly terbinafine-resistant strain in Sri Lanka, and existence of this species should be taken seriously by dermatologists and healthcare policymakers for better management of tinea infections and antifungal stewardship in the country.


  • Open Access

    Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis

    by Nidhi S. Dey, Sujai Senaratne, Vijani Somaratne, Nayani P. Madarasinghe, Bimalka Seneviratne, Sarah Forrester, Marcela Montes de Oca, Luiza Campos Reis, Srija Moulik, Pegine B. Walrad, et al.

  • Open Access

    Polymorphic light eruption-like lesions in association with cutaneous leishmaniasis – is it a unique leishmanid reaction in Leishmania donovani cutaneous leishmaniasis in Sri Lanka?

    by N. P. Madarasingha, P. K. Idirisinghe

    Cutaneous leishmaniasis (CL) in Sri Lanka is caused by Leishmania donovani species, which usually causes visceral leishmaniasis in neighboring countries. We report a case series of 54 patients with cutaneous leishmaniasis from Anuradhapura, Sri Lanka, with associated polymorphic light eruption (PMLE) like lesions. As these PMLE-like lesions show characteristic features of an id reaction, we propose that this could be a leishmanid reaction. To date, PMLE-like leishmanid reactions are not reported in association with other leishmania species. Therefore, we suspect that PMLE-like leishmanid reaction could be a unique association of Leishmania donovani CL that occur in Sri Lanka.

  • Open Access

    Characterization of Recalcitrant Dermatophytosis in a Multicenter Study in Sri Lanka

    by Nayani P. Madarasingha, Surammika Eriyagama, Primali I. Jayasekera, Shreenika de Silva Weliange, Saman Gunasekera, D. M. Munasingha, Premini Rajendran, S. M. B. Ekanayaka, Janani Liyanange, N. Thamilvannan, et al.

    : A changing clinical scenario of dermatophytosis has been observed in Sri Lanka during the past few years. In keeping with the trend described in India, an increase in the number of chronic, relapsing, and recalcitrant infections has been noted. The objective of our study was to assess the therapeutic response of dermatophytosis to standard antifungal treatment in Sri Lanka and to identify possible contributory factors in cases showing inadequate therapeutic response. A descriptive, observational, cross-sectional study was carried out in nine hospitals, representing each province. Over 6 months, patients with dermatophytosis on glabrous skin were included. All subjects underwent skin scrapings for mycological studies and were treated with a standard course of antifungals for a specific period. In those patients who achieved complete clearance, recurrences were noted. The study included 796 patients, of whom 191 (24%) had symptoms for more than 3 months at presentation. A total of 519 patients (65.2%) had multiple-site involvement, and 503 (63.2%) had evidence of prior use of topical steroids. Skin scrapings were positive for fungal elements in the direct smears of 659 patients (82.8%), and the predominant dermatophyte isolated was Trichophyton mentagrophytes (65.6%). Partial responders after 10 weeks of treatment and recurrences after complete clearance were significantly greater in the group that used topical steroids before presentation (P < 0.001). This study highlights the magnitude of the threat of an inadequate therapeutic response in dermatophytosis in Sri Lanka, and identifies steroid misuse, and the shift of the predominant fungal species to T. mentagrophytes as possible causative factors.


  • Open Access

    Disseminated Fusarium infection in an immunocompromised patient Successful outcome with combined antifungal therapy

    by U. A. B. P. Somawardana, N. P. Madarasinga, M. A. N. Manchanayaka, C. N. Wijesinghe, G. D. I. Premathilaka, P. G. R. I. S. Welagedara, L. S. M. Sigera, S. P. Gunasekera, P. I. Jayasekera

  • Open Access

    Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis

    by Nidhi S. Dey, Sujai Senaratne, Vijani Somaratne, Nayani P. Madarasinghe, Bimalka Seneviratne, Sarah Forrester, Marcela Montes de Oca, Luiza Campos Reis, Srija Moulik, Pegine B. Walrad, et al.

    Cutaneous leishmaniasis (CL) is caused by Leishmania donovani in Sri Lanka. Pentavalent antimonials (e.g., sodium stibogluconate [SSG]) remain first-line drugs for CL with no new effective treatments emerging. We studied whole blood and lesion transcriptomes from Sri Lankan patients with CL at presentation and during SSG treatment. From lesions but not whole blood, we identified differential expression of immune-related genes, including immune checkpoint molecules, after onset of treatment. Using spatial profiling and RNA-FISH, we confirmed reduced expression of programmed death-ligand 1 (PD-L1) and indoleamine 2,3-dioxygenase 1 (IDO1) proteins on treatment in lesions of a second validation cohort and further demonstrated significantly higher expression of these checkpoint molecules on parasite-infected compared with noninfected lesional CD68+ monocytes and macrophages. Crucially, early reduction in PD-L1 but not IDO1 expression was predictive of rate of clinical cure (HR = 4.88) and occurred in parallel with reduction in parasite load. Our data support a model whereby the initial anti–leishmanial activity of antimonial drugs alleviates checkpoint inhibition on T cells, facilitating immune-drug synergism and clinical cure. Our findings demonstrate that PD-L1 expression can be used as a predictor of rapidity of clinical response to SSG treatment in Sri Lanka and support further evaluation of PD-L1 as a host-directed therapeutic in leishmaniasis.